Skip to main content
. 2022 Jul 22;36(11):2101–2112. doi: 10.1111/jdv.18409

Figure 6.

Figure 6

Cumulative incidence of first biologic switch with competing risks of biologic discontinuation or inclusion in a clinical trial. *Number of patients free from any event. [Colour figure can be viewed at wileyonlinelibrary.com]